Avricore Health Inc.
AVCR.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 77.00K | -4.20K | -255.30K | -521.90K | -746.00K |
| Total Depreciation and Amortization | 336.40K | 343.40K | 330.20K | 308.70K | 266.40K |
| Total Amortization of Deferred Charges | 8.70K | 6.60K | 4.40K | 2.50K | 5.00K |
| Total Other Non-Cash Items | 370.40K | 349.40K | 473.60K | 525.70K | 602.80K |
| Change in Net Operating Assets | -124.40K | -65.90K | 168.70K | 174.00K | 160.80K |
| Cash from Operations | 668.10K | 629.20K | 721.70K | 489.10K | 288.90K |
| Capital Expenditure | -381.80K | -531.60K | -648.00K | -756.40K | -820.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -25.70K | -25.10K | -20.90K | -18.70K | -13.10K |
| Cash from Investing | -407.40K | -556.70K | -668.90K | -775.10K | -833.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -30.00K | -30.00K | -30.00K | -- | -- |
| Issuance of Common Stock | 69.10K | 16.60K | 30.60K | 42.50K | 257.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.50K | -10.00K | 500.00 | 31.50K | 189.80K |
| Foreign Exchange rate Adjustments | 0.00 | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 289.20K | 62.50K | 53.20K | -254.60K | -354.80K |